ORGAN DONATION: A Human Liver Was Successfully Transplanted After Being Processed In A Machine.
The team says that the
organ recipient is still doing remarkably well one year after the
groundbreaking treatment.
"The patient quickly
restored a normal quality of life without any evidence of liver damage,"
the Liver4Life study team stated in a paper published in the journal Nature
Biotechnology on Tuesday.
The 62-year-old
transplant recipient said in a statement, "I am very grateful for the
life-saving organ." "I had limited possibility of acquiring a liver
from the waiting list in a fair amount of time due to my quickly developing tumor"
The patient's identity was kept a secret.
Dr. Pierre-Alain Clavien, who was the surgeon, stands with the patient (right) as he was discharged from the hospital after the successful transplantation last year. |
Only the first six weeks
following surgery were given basic immunosuppressants.
Connecting the liver to
the machine allows it to be treated with antibiotics or hormonal medicines, as
well as conduct long laboratory or tissue testing without being rushed. Under
normal conditions, this is not practicable because organs can only be preserved
on ice and in commercially accessible perfusion devices for a maximum of 12
hours.
Even totally healthy
donor livers can only be kept outside the human body for roughly 12 hours in
normal cold storage or up to 24 hours in a perfusion system like the one
developed by the scientists. Doctors must "assess, transport, and implant
donor grafts for human transplantation" within that time frame, according
to the paper, which limits not only the distance these organs can travel before
reaching a recipient and the room for error during transport, but also
effectively eliminates the possibility of repairing an organ prior to
transplantation.
"Our therapy
indicates that treating livers in a perfusion machine can alleviate the loss of
functioning human organs and save lives," Prof Clavien stated.
"The
interdisciplinary approach to overcoming complex health challenges inherent in
this study is the future of medicine," said Mark Tibbitt, professor of
macromolecular engineering at ETH Zurich.
"We will be able to
employ new findings for treating patients even faster as a result of
this."
The research was
published in the journal Nature Biotechnology.
ORGAN DONATION |
0 Comments
Please do let me know if you need any further assistance